CLINICAL_TRIALS
ClinicalTrials.gov record update
Impact of Daily Prophylaxis Dose Anticoagulation With a Factor Xa Inhibitor (Apixaban) in Patients With Sickle Cell Disease
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02179177
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:47.518001+00:00
- Published At
- 2020-03-11T00:00:00+00:00
- Record Updated At
- 2020-03-11
- Results Posted At
- 2020-03-11
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Vaso-occlusive Crisis", "Reduction in Hospitalizations", "Sickle Cell Disease"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-03-11"- protocolSection.identificationModule.nctId
"NCT02179177"- protocolSection.identificationModule.officialTitle
"Impact of Daily Prophylaxis Dose Anticoagulation With a Factor Xa Inhibitor (Apixaban) in Patients With Sickle Cell Disease"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-03-11"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.